ICON8: A GCIG phase III randomised trial evaluating weekly dosedense chemotherapy integration in first- line epithelial ovarian/fallopian tube/primary peritoneal carcinoma (EOC) treatment: Results of primary progression- free survival (PFS) analysis
मुख्य लेखकों: | Clamp, A, McNeish, I, Dean, A, Gallardo, D, Weon-Kim, J, O'Donnell, D, Hook, J, Coyle, C, Blagden, S, Brenton, J, Naik, R, Perren, T, Sundar, S, Cook, A, James, E, Swart, A, Stenning, S, Kaplan, R, Ledermann, J |
---|---|
स्वरूप: | Conference item |
प्रकाशित: |
Oxford University Press
2017
|
समान संसाधन
-
Response to neoadjuvant chemotherapy in ICON8: A GCIG phase III randomised trial evaluating weekly dose-dense chemotherapy integration in first-line epithelial ovarian/fallopian tube/primary peritoneal carcinoma (EOC) treatment
द्वारा: Clamp, A, और अन्य
प्रकाशित: (2018) -
Quality of life of weekly, dose-dense versus standard chemotherapy for ovarian cancer in the ICON8 study
द्वारा: Blagden, S, और अन्य
प्रकाशित: (2017) -
Primary fallopian tube carcinoma
द्वारा: Ben-Shian Huang, और अन्य
प्रकाशित: (2012-03-01) -
Primary Fallopian Tube Carcinoma
द्वारा: Prasad K Shetty, और अन्य
प्रकाशित: (2011-01-01) -
Principles of emergency management and emergency operations centers (EOC) /
द्वारा: Fagel, Michael J.
प्रकाशित: (2011)